LIGAND PHARMACEUTICALS INC
United States · Industrial & Consumer Products · LGNXZ
Temel Finansal Göstergeler (2024)
- ROE (2024)
- 1.67%
- ROA (2024)
- 73.97%
- Brüt Kâr Marjı (2024)
- 100%
- Net Kâr Marjı (2024)
- 76.16%
- Toplam Varlıklar (2024)
- $2.2M
- Net Kâr (2024)
- $16.2K
- Değerleme (2024)
- $4.9M
- Hisse Fiyatı (2024)
- $0.0
Tarihsel Performans ve Projeksiyon
LIGAND PHARMACEUTICALS INC için Equlion'un yapay zeka modelinin ürettiği 12 yıllık projeksiyon.
| Gösterge | 2024 | Yıl 1 | Yıl 2 | Yıl 3 | Yıl 4 | Yıl 5 | Yıl 6 | Yıl 7 | Yıl 8 | Yıl 9 | Yıl 10 | Yıl 11 | Yıl 12 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 1.67% | 1.54% | 1.53% | 1.51% | 1.5% | 1.48% | 1.47% | 1.45% | 1.44% | 1.43% | 1.41% | 1.4% | 1.39% | |
| ROA | 73.97% | 68.55% | 68.25% | 67.94% | 67.64% | 67.33% | 67.02% | 66.72% | 66.42% | 66.12% | 65.82% | 65.52% | 65.22% | |
| Brüt Kâr Marjı | 100% | 88.5% | 88.5% | 88.49% | 88.49% | 88.48% | 88.48% | 88.48% | 88.47% | 88.47% | 88.47% | 88.46% | 88.46% | |
| Net Kâr Marjı | 76.16% | 70.86% | 70.85% | 70.85% | 70.85% | 70.84% | 70.83% | 70.83% | 70.82% | 70.82% | 70.81% | 70.81% | 70.8% | |
| Toplam Varlıklar | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | $2.2M | |
| Net Kâr | $16.2K | $15.0K | $29.9K | $44.8K | $14.8K | $29.5K | $44.2K | $58.7K | $73.3K | $87.7K | $102.1K | $116.4K | $130.7K | |
| Değerleme | $4.9M | $4.9M | $4.9M | $4.9M | $4.9M | $4.9M | $4.9M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | |
| Hisse Fiyatı | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
LIGAND PHARMACEUTICALS INC için 1-3-5 yıllık tam finansal tahmin raporu (bilanço, gelir tablosu, nakit akışı ve senaryo analizi) oluşturmak ister misiniz?